Fact CheckerSign in

NCT04242992Completed

Effectiveness of Transdiagnostic Cognitive Behavioral Therapy for Improving HIV Treatment Outcomes in South Africa

Testing the Effectiveness of an Evidence-based Transdiagnostic Cognitive Behavioral Therapy Approach for Improving HIV Treatment Outcomes Among Violence-affected and Virally Unsuppressed Women in South Africa

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

This study will evaluate the impact of the Common Elements Treatment Approach (CETA), an evidence-based intervention comprised of cognitive-behavioral therapy elements, at improving HIV treatment outcomes among women with HIV who have experienced intimate partner violence (IPV) and have an unsuppressed viral load on HIV treatment. To evaluate CETA, the investigators will conduct a randomized controlled trial of HIV-infected women, with or without their partners, who have experienced IPV and have an unsuppressed viral load to test the effect of CETA in increasing viral suppression and reducing violence. The investigators will also identify mediators and moderators of CETA's effect on retention and viral suppression and assess the cost and cost-effectiveness of CETA vs. active control at increasing the proportion who are retained and virally suppressed by 12 months.

Status (registry)
Completed
Study type
Interventional
Enrollment
399 (actual)
First submitted
23 Jan 2020
Start date
12 Nov 2021
Primary completion date
23 May 2025
Lead sponsor
Boston University
Diseases
HIV
NCT number
NCT04242992

What you commit to

  • Study type: Interventional
  • Participants enrolled: 399
  • From 12 Nov 2021 to the primary completion date, 23 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Currently psychotic or on unstable psychiatric regimen
  • Enrolled in any other HIV treatment intervention study

Other

  • Unwilling to complete the informed consent process
  • Suicide attempt/ideation with intent and plan, and/or self-harm in the past month

Who the study is looking for

  • Adult HIV positive women
  • Initiated HIV treatment
  • Most recent viral load \>50 copies/mL or they have defaulted from treatment or had a missed or late (\>14 days) visit in the last year
  • Has experienced IPV in the past 12 months
  • Has their own phone and can receive text messages
  • Literate and able to speak and read one of: English, Zulu, SeSotho
  • If including a partner, the woman has disclosed HIV status to the partner that will be invited to participate (noting that male partners are not study subjects, only the woman is)

Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
HIV Clinic
Coordinator of this site? Confirm its status
JohannesburgSouth AfricaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.